SPDR S&P Biotech ETF (NYSEARCA:XBI) Stake Raised by Greenwich Wealth Management LLC

Greenwich Wealth Management LLC increased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 10.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,505 shares of the exchange traded fund’s stock after buying an additional 1,073 shares during the quarter. Greenwich Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $1,067,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Avoro Capital Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth approximately $396,844,000. Healthcare of Ontario Pension Plan Trust Fund lifted its position in SPDR S&P Biotech ETF by 30.3% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after purchasing an additional 730,000 shares during the period. Jane Street Group LLC boosted its stake in SPDR S&P Biotech ETF by 68.7% during the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock valued at $91,197,000 after purchasing an additional 391,333 shares in the last quarter. Bessemer Group Inc. increased its position in shares of SPDR S&P Biotech ETF by 1.7% during the 1st quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock valued at $87,572,000 after purchasing an additional 15,794 shares during the period. Finally, Mirae Asset Securities USA Inc. acquired a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at $55,626,000.

SPDR S&P Biotech ETF Stock Up 2.2 %

Shares of SPDR S&P Biotech ETF stock opened at $101.21 on Monday. The business has a fifty day simple moving average of $98.48 and a 200-day simple moving average of $93.85. SPDR S&P Biotech ETF has a fifty-two week low of $63.80 and a fifty-two week high of $103.52. The firm has a market cap of $7.71 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.